| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8441498 | European Journal of Cancer | 2016 | 10 Pages |
Abstract
In HRÂ +Â /HER2â patients, the CPSÂ +Â EG staging system retains its ability to facilitate a refined stratification of patients according to outcome. It can help to select candidates for post-neoadjuvant clinical trials in luminal breast cancer.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Frederik Marmé, Bianca Lederer, Jens-Uwe Blohmer, Serban Dan Costa, Carsten Denkert, Holger Eidtmann, Bernd Gerber, Claus Hanusch, Jörn Hilfrich, Jens Huober, Christian Jackisch, Sherko Kümmel, Sibylle Loibl, Stefan Paepke, Michael Untch,